The SARS-CoV-2 strain (registration number 43326) used in this study was isolated from a Korean patient traveling to China (the National Culture Collection for Pathogens) (Cheongju, Korea). Following plaque purification of SARS-CoV-2, this virus was cultivated twice in VERO cells with Dulbecco’s minimum essential medium (Welgene Inc., Daegu, Korea) containing 2% fetal bovine serum and 1% penicillin (10,000 IU/ml)/streptomycin (10,000 IU/ml) (Gibco, NY, United States) at 37°C in a 5% CO2 incubator. At 3 days postinoculation (dpi), the cell supernatant was collected, centrifuged at 3,000 g for 10 min, and stored at −80°C. Virus titration was performed using VERO cells, and the 50% tissue culture infectious dose 50/ml (TCID50/ml) was calculated according to the Reed–Muench method (Reed and Muench, 1938).

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。